The firm is currently offering vaginal mesh lawsuit evaluations to women who allege they sustained injuries from vaginal mesh implants.

The Rottenstein Law Group LLP, a New York-based law firm that represents hundreds of plaintiffs in transvaginal mesh lawsuits, acknowledges a study comparing the results of pelvic prolapse repair using vaginal mesh and native tissue.

The results of a prospective randomized trial, which were reported by Dr. Robert E. Gutman at the annual meeting of the Society of Gynecologic Surgeons, showed that cure rates and patient satisfaction following pelvic prolapse repair were similar at three-year follow-up regardless of whether vaginal mesh or native tissue was used for the repair, according to the May 9, 2013, article in Ob.Gyn.News that reported on the study.* That article further reports that, “subjects treated with mesh had more complications without experiencing benefit beyond that observed in the native tissue repair patients.”

Read full story at PRWeb.com: Rottenstein Law Group LLP Acknowledges Study That Raises Questions About Use of Vaginal Mesh For Prolapse Repair

The Food and Drug Administration (FDA), as well as the medical device community, are hoping that device failure will be reduced dramatically which may translate to lower product recall. This optimism is grounded on the successful performance of the Medical Device Innovation Consortium (MDIC).
 
With the establishment of the MDIC, the FDA is hoping that bureaucratic red tape in getting a medical device approval in the United States will be eliminated. This consortium will act as a public-private partnership that will support the medical device community by assisting various organizations in gaining access to resources from government, private, and academic sectors.
 
They are confident that with this collaboration, research and development of new devices will result to quality products. Furthermore, it is hoped that testing will be more rigid and exhaustive in order to ensure that products are truly safe and effective.
 
A very positive sign is the active cooperation shown by industry players. In just a few months, the consortium has already raised half a million dollars for their development projects.
 
Read More: FDA to Collaborate With Medical Devices Industry to Speed Up Development of New Technology